Fatty liver disease (MASLD/MASH) trials in China

In China 73 Also abroad 369

33 of 73 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
Where
Taiyuan
Age
18 years to 79 years
People
25,974
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07884903
No phaseTaking people
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
Where
Beijing
Age
18 years to 70 years
People
500
Run by
Beijing Friendship Hospital
See details and how to joinNCT03635541
No phaseTaking people
Digital Early Warning System for Acute Lung Injury in Liver Surgery
Where
Beijing, Chongqing, Qingdao
Age
18 years and over
People
3,000
Run by
Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT07070362
No phaseTaking people
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Where
Hong Kong
People
1,500
Run by
Humanity and Health Research Centre
See details and how to joinNCT02863757
No phaseTaking people
Nonalcoholic Steatohepatitis in Chinese Children
Where
Beijing
Age
1 year to 18 years
People
400
Run by
Humanity and Health Research Centre
See details and how to joinNCT03190538
No phaseNot yet taking people in China
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
Where
Hanzhou
Age
18 years and over
People
7,000
Run by
The Affiliated Hospital of Hangzhou Normal University
See details and how to joinNCT07706010
No phaseTaking people
Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Where
Beijing
Age
18 years and over
People
470
Run by
Novo Nordisk A/S
See details and how to joinNCT07682363
No phaseNot yet taking people in China
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV
Where
Shanghai
Age
18 years to 80 years
People
120
Run by
Yinzhong Shen
See details and how to joinNCT07640880
No phaseTaking people
Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
Where
Bengbu, Guangzhou, Haikou, Hangzhou, Hefei, Hengyang, Kunming, Nanjing, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Weifang, Wenzhou, Wuhan, Wuhu, Xi’an, Xuzhou, Zhengzhou, Zunyi
Age
18 years and over
People
10,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07632677
No phaseTaking people
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Where
Beijing
People
2,000
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05330923
No phaseTaking people
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
Where
Hangzhou
Age
65 years to 100 years
People
20,000
Run by
The Affiliated Hospital of Hangzhou Normal University
See details and how to joinNCT07241195
No phaseNot yet taking people in China
Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD
Where
Guangzhou
Age
18 years to 75 years
People
700
Run by
First Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT07545343
No phaseTaking people
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Where
Guangzhou
People
240
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07265544
No phaseTaking people
High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps
Where
Shanghai
Age
18 years to 70 years
People
100
Run by
Shanghai East Hospital
See details and how to joinNCT07463287
No phaseNot yet taking people in China
An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease
Where
Guangzhou
Age
18 years and over
People
200
Run by
Zhujiang Hospital
See details and how to joinNCT07455149
No phaseTaking people
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
Where
Wuhan
People
500
Run by
Tongji Hospital
See details and how to joinNCT07149571
No phaseNot yet taking people in China
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
Where
Beijing, Changsha, Changzhi, Foshan, Fuzhou, Guangzhou, Guiyang, Jincheng, Jinzhong, Lanzhou, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Shiyan, Taiyuan, Zhuhai
Age
18 years to 75 years
People
735
Run by
Beijing Friendship Hospital
See details and how to joinNCT07087041
No phaseNot yet taking people in China
Prognostic Model for MASLD Related Cirrhosis
Where
Beijing, Tianjin
Age
18 years to 80 years
People
228
Run by
Beijing Friendship Hospital
See details and how to joinNCT07082751
No phaseTaking people
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
Where
Ningbo
Age
20 years to 90 years
People
2,720
Run by
Ningbo No. 1 Hospital
See details and how to joinNCT06984510
No phaseEnrolling by invitation
Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia
Where
Ningbo
Age
18 years to 100 years
People
17,040
Run by
Ningbo No. 1 Hospital
See details and how to joinNCT07001865
No phaseTaking people
An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Where
Shanghai
Age
18 years and over
People
337
Run by
Shanghai East Hospital
See details and how to joinNCT06939569
No phaseTaking people
Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
Where
Chongqing
Age
18 years to 90 years
People
7,000
Run by
Chongqing Medical University
See details and how to joinNCT05974904
No phaseNot yet taking people in China
Clinical Classification of MAFLD Based Liver Biopsy
Where
Beijing, Hangzhou, Shanghai, Tianjin
People
2,000
Run by
Beijing Friendship Hospital
See details and how to joinNCT06795646
No phaseTaking people
LivQ-box® Parameters in the Diagnosis of Liver Inflammation
Where
Beijing
Age
18 years and over
People
365
Run by
Wuxi Hisky Medical Technology Co Ltd
See details and how to joinNCT06802731
No phaseTaking people
Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
Where
Beijing
Age
18 years to 70 years
People
50
Run by
Beijing Municipal Administration of Hospitals
See details and how to joinNCT06707129